Remove alliance worth
article thumbnail

Sanofi signs $1.2bn research alliance with AI specialist Insilico

pharmaphorum

Sanofi has tapped into the artificial intelligence expertise of Chinese biotech Insilico Medicine with a six-compound drug discovery collaboration that could be worth up to $1.2 The alliance is backloaded, with $21.5 The post Sanofi signs $1.2bn research alliance with AI specialist Insilico appeared first on.

Pharma 93
article thumbnail

UK, Moderna formalise 10-year vaccines alliance

pharmaphorum

Construction will start early next year of a new manufacturing centre in the UK with the capacity to produce 250 million vaccine doses per year, the centrepiece of a 10-year alliance between the government and US biotech Moderna. The first vaccines are due to be produced at the new facility in 2025.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca starts 2023 with $1.8 billion cardiovascular acquisition

Pharmaceutical Technology

billion, which along with maximum potential contingent payments would make the deal worth $1.8 We have indicated to investors that we want to be a sustainably growing company, so until 2025 we have strong growth ahead of us, but we also continue to believe that we can grow very strongly past 2025,” said Soriot. Free Report.

article thumbnail

4 Ways to Meet the Needs of an Increasing Health-conscious Audience

PM360

By 2025, sales of consumer health products are expected to reach $368bn, according to Euromonitor, encompassing everything from sleep aids to vitamins to sports nutrition products. Additionally, Walgreens Boots Alliance (WBA) has made a $5.2 The consumer health market is anticipated to grow significantly in the coming years.

Retail 97
article thumbnail

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

Pharmaceutical Technology

Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund. An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%.

Pharma 84
article thumbnail

AION Labs and BioMed X launch sixth challenge for AI-driven drug discovery

Pharmaceutical Technology

Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund. An analysis from GlobalData forecasted $3.3bn worth of spending on AI in drug discovery by 2025, more than triple the $1bn spent in 2019, and a year-on-year growth of 24.4%.

Pharma 52